SCHEMBL2809658

SCHEMBL2809658

O=C(N[C@@]1(C(=O)NCc2ccc(Nc3ccccc3C(F)(F)F)cc2)CCOC1)c1cnccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP2C9 P11712 2/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
AURKA O14965 1/20 0.38
RAB9A P51151 3/20 0.38
CYP3A4 P08684 2/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 2/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
BDKRB1 P46663 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13128481 0.87 CTDSP1 (0.35) HPGDNPSR1AURKAALDH1A1KMT2A
SCHEMBL2811096 0.87 NAMPT (0.41) AURKAMEN1KMT2ABDKRB1TRPV1
SCHEMBL2811098 0.87 NAMPT (0.41) AURKAMEN1KMT2ABDKRB1TRPV1
SCHEMBL185912 0.87 AURKA (0.36) AURKAMEN1KMT2ATDP1BDKRB1
SCHEMBL2806710 0.86 BDKRB1 (0.46) HPGDNPSR1AURKAALDH1A1MAPT
SCHEMBL2807542 0.86 NAMPT (0.39) HPGDNPSR1AURKAALDH1A1MAPT
SCHEMBL2804848 0.85 BDKRB1 (0.38) HPGDNPSR1AURKAALDH1A1MAPT
SCHEMBL13128468 0.85 BDKRB1 (0.38) HPGDNPSR1AURKAALDH1A1MAPT
SCHEMBL2805433 0.85 AR (0.38) SMN1; SMN2RAB9ANPC1BDKRB1
SCHEMBL13128509 0.85 CTDSP1 (0.35) HPGDNPSR1AURKARAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 CYP1A2 892/4885CYP2C19 136/4885SMN1; SMN2 4025/4885
US-20100240669-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 CYP1A2 892/4885CYP2C19 136/4885SMN1; SMN2 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.